Health Canada drug identification number

DIN 02373041 — MYLAN-LATANOPROST 50 MCG

MYLAN-LATANOPROST is a solution of Latanoprost marketed by MYLAN PHARMACEUTICALS ULC. The full Latanoprost monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02373041
Brand name
MYLAN-LATANOPROST
Active ingredient
Latanoprost
Strength
50 MCG
Dosage form
SOLUTION
Route
OPHTHALMIC
Manufacturer
MYLAN PHARMACEUTICALS ULC
Health Canada status
MARKETED
Drug class
Prostaglandin F2α analogue (ophthalmic intraocular pressure-lowering agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Latanoprost products

DINBrandStrengthFormManufacturerStatus
02534835 AG-LATANOPROST 50 MCG SOLUTION ANGITA PHARMA INC. MARKETED
02296527 APO-LATANOPROST 50 MCG SOLUTION APOTEX INC MARKETED
02453355 JAMP LATANOPROST 50 MCG SOLUTION JAMP PHARMA CORPORATION MARKETED
02513285 M-LATANOPROST 50 MCG SOLUTION MANTRA PHARMA INC MARKETED
02426935 MED-LATANOPROST 50 MCG SOLUTION GENERIC MEDICAL PARTNERS INC MARKETED
02456230 MONOPROST 50 MCG SOLUTION LABORATOIRES THEA MARKETED
02317125 PMS-LATANOPROST 50 MCG SOLUTION PHARMASCIENCE INC DORMANT
02341085 RIVA-LATANOPROST 50 MCG SOLUTION LABORATOIRE RIVA INC. MARKETED
02367335 SANDOZ LATANOPROST 50 MCG SOLUTION SANDOZ CANADA INCORPORATED MARKETED
02231493 XALATAN 50 MCG SOLUTION BGP PHARMA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.